Seropositive pSS (n= 95) versus controls (n= 136) | Seropositive pSS (n= 199) versus controls (n= 534) | Seropositive (n= 191) versus seronegative pSS (n= 80) | Seronegative pSS (n= 82) versus controls (n= 534) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cohort 1: DRB1-typing | Cohort 2: DR3 proxy SNPa | Cohort 2: DR3 SSPa | Cohort 2: DR3 proxy SNPa | |||||||||
Term | β | SE | P | β | SE | P | β | SE | P | β | SE | P |
β0 (Intercept 1) | -1.64 | 0.28 | <0.001 | -0.01 | 2.64 | 1 | -3.97 | 4.31 | 0.36 | 1.04 | 3.32 | 0.75 |
β1 (DR3-pos) | 2.23 | 0.37 | <0.001 | 1.35 | 0.21 | <0.001 | 1.39 | 0.37 | <0.001 | 0.28 | 0.33 | 0.40 |
β2 (P2RX7_1405G) | 1.11 | 0.38 | 0.003 | 0.26 | 0.22 | 0.24 | 0.25 | 0.34 | 0.46 | 0.29 | 0.27 | 0.28 |
β3 (DR3*1405G) | -1.27 | 0.53 | 0.016 | -0.76 | 0.35 | 0.027 | -1.27 | 0.56 | 0.023 | 0.02 | 0.47 | 0.96 |